NPM1 and acute myeloid leukemia: In summary, the most important targets for monitoring MRD in AML are FLT3-ITD and NPM1. The input DNA amount ranges from 100 to 700 ng, and sequencing can be performed by both Illumina and Thermo Fisher platforms.